CRMD, CELC, RANI, and RAPT are pushing aggressively to the upside on Monday. Here's what is driving these four biotech stocks ...

Biotech stocks rebound after years of weakness as M&A, lower rates and easing policy fears draw investors back to the sector.

Leverage RWE strategically to build regulator-ready submissions.

Home to a well-established hub with strong investment and startup activity, discover what makes Cambridge's biotech scene so ...

Claude for Life Sciences is based on Anthropic’s most powerful large language model Claude Sonnet 4.5. It’s designed to ...

After years on the sidelines while investors piled into the next big thing in AI or crypto, biotech is back in focus.

Advanced biotech equipment, driven by R&D investment and personalized medicine, is essential for scalable drug production and ...

BIOSPAIN showed how partnering conferences connect public funding, venture capital, and pharma to drive biotech innovation to ...

Acadia Pharmaceuticals CEO Catherine Owen Adams breaks down the company’s recent rebrand, its expansion into rare disease marketing and how it’s using AI.

Oncolytics Biotech (ONCY) has established a new at-the-market equity financing agreement with BTIG, LLC. As disclosed in a Securities and Exchange Commission ((SEC)) filing on October 17, 2025, the de ...

The biomedical research facility in South Jersey is expected to create about 150 new permanent jobs plus 100 construction ...

The Pennsylvania Biotechnology Center of Bucks County is looking at developing a new laboratory and office building on a 2.85 ...